Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6367 studies found for:    "Liver Diseases"
Show Display Options
Rank Status Study
21 Recruiting Nutritional Assessment Tool and Nutritional Intervention in Childhood Chronic Liver Disease
Condition: Chronic Liver Disease
Interventions: Dietary Supplement: Nutritional Supplement;   Dietary Supplement: Standard Nutritional Treatment
22 Recruiting Trial to Examine the Effect of Two Doses of GRI-0621 in Patients With Chronic Liver Disease
Condition: Chronic Liver Disease
Interventions: Drug: Placebo Comparator;   Drug: Active Comparator:4.5mg GRI-0621;   Drug: Active Comparator: 6.0mg GRI-0621
23 Recruiting Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease
Condition: Chronic Liver Disease
Intervention:
24 Completed Study to Evaluate Efficacy and Safety of PENNEL Capsule in the Patients With Chronic Liver Disease
Condition: Chronic Liver Disease
Interventions: Drug: NISSEL;   Drug: PENNEL
25 Completed
Has Results
Effect of Probiotics on Gut-Liver Axis of Alcoholic Liver Disease
Condition: Alcoholic Liver Disease
Interventions: Drug: hepatitis, alcohol, probiotics;   Drug: alcohol, hepatitis, Placebo
26 Completed G-CSF and Erythropoetin in Survival of Patients With Decompensated Liver Disease
Condition: Chronic Liver Disease
Interventions: Drug: G-CSF+EPO;   Drug: Placebo
27 Recruiting Development and Assessment of The Polycystic Liver Disease Questionnaire (PLD-Q).
Condition: Polycystic Liver Disease
Intervention: Other: PLD-Q
28 Completed Determination of Liver Stiffness in Chronic Liver Disease Patients by Acoustic Radiation Force Imaging (ARFI) Ultrasound
Condition: Chronic Liver Disease
Intervention: Device: Acoustic Radiation Force Imaging
29 Completed The Physiology of Fatigue in Patients With Chronic Liver Disease
Condition: Liver Disease
Intervention:
30 Completed To Evaluate the Efficacy of DDB/Garlic Oil in Patients With Elevated Transaminase Chronic Liver Disease
Condition: Chronic Liver Disease
Interventions: Drug: Pennel;   Drug: Legalon;   Drug: Placebo
31 Completed Study to Evaluate Efficacy, Safety and Tolerability of PENNEL Capsule in the Patients With Chronic Liver Disease
Condition: Chronic Liver Disease
Interventions: Drug: PENNEL capsule;   Drug: Placebo
32 Completed Long Term Effect of Aggressive Nutritional Management on Survival in Patients With Alcoholic Liver Disease
Condition: Alcoholic Liver Disease
Interventions: Dietary Supplement: Polymeric nutritional supplements;   Dietary Supplement: Standard Nutrional Treatment
33 Active, not recruiting Early Intervention and Prevention of Non-Alcoholic Fatty Liver Disease in Adolescents
Condition: Non-alcoholic Fatty Liver Disease
Interventions: Behavioral: Experimental: Low-fructose, reduced carbohydrate diet;   Behavioral: General Healthy Diet
34 Completed Plasma Betatrophin Levels in Non-alcoholic Fatty Liver Disease
Condition: Non-alcoholic Fatty Liver Disease
Intervention:
35 Recruiting Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Condition: Thrombocytopenia Associated With Liver Disease
Interventions: Drug: avatrombopag (lower baseline platelet count);   Drug: placebo (lower baseline platelet count);   Drug: avatrombopag (higher baseline platelet count);   Drug: placebo (higher baseline platelet count)
36 Recruiting Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Condition: Thrombocytopenia Associated With Liver Disease
Interventions: Drug: avatrombopag (lower baseline platelet count);   Drug: placebo (lower baseline platelet count);   Drug: avatrombopag (higher baseline platelet count);   Drug: placebo (higher baseline platelet count)
37 Recruiting The Effect of Acetaminophen on Non-alcoholic Fatty Liver Disease Patients
Condition: Non-alcoholic Fatty Liver Disease (NAFLD)
Intervention: Drug: Acetaminophen
38 Completed End Stage Liver Disease and Body Composition Assessment: Utilizing Bioelectric Impedance Analysis (BIA)
Condition: End Stage Liver Disease
Interventions: Device: Bodystat Quadscan 4000;   Device: bodystat quadscan 400
39 Unknown  Mobilization of Stem Cells With G-CSF and Mozobil in Patients With End Stage Liver Disease
Condition: End Stage Liver DIsease
Intervention: Drug: Mobilization with G-CSF and Mozobil
40 Completed
Has Results
Magnetic Resonance Spectroscopy (MRS) Validation Study in Individuals With Nonalcoholic Fatty Liver Disease (NAFLD)
Condition: Liver Diseases
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.